Antiviral activity of rosemary extract against Zika virus in human dermal fibroblasts
Jordan T. MasiiD, Robert W. E. CrozieriD, Jeremia M. CoishiD, Natalie J. HicksiD, Carmela A. Lowes, Evangelia TsianiiD, Dustin DuncaniD, Edward I. PattersoniD, Adam J. MacNeiliD
Abstract
Flaviviruses have increasingly emerged and re-emerged in recent decades, infecting millions of people annually. Zika virus (ZIKV) is particularly concerning due to its associated pathological complications, including microcephaly in newborns and Guillain-Barre syndrome in adults, posing a significant threat to public health. Despite efforts made by the scientific community, no licensed drugs against flaviviruses have been developed. Medicinal plants show promise as a novel source of antiviral agents, as they possess a diverse array of biologically active secondary metabolites, making them potential candidates for therapeutic use. Here, we sought to investigate the antiviral potential of rosemary extract (RE) against ZIKV in human dermal fibroblasts (HFF-1), one of the earliest cellular targets of infection. ZIKV was treated with various concentrations of RE or its major polyphenols, including rosmarinic acid (RA), carnosic acid (CA), and carnosol (CO), and the infectivity of each sample was measured by plaque reduction assay. To evaluate the impact of RE on different stages of the ZIKV replication cycle, HFF-1 cells were treated before, during, and after infection, or the virus was treated before infection. RE exerted potent virucidal activity against ZIKV in both Vero and HFF-1 cells by directly acting on virus particles before infection. Importantly, RE significantly inhibited the later stages of the virus replication cycle by interfering with post-entry mechanisms within the host cell. Moreover, major RE-derived polyphenols CA and CO, but not RA, were shown to significantly reduce infectivity when ZIKV was pre-treated with each compound individually. Overall, RE significantly impairs ZIKV infection in vitro by directly interacting with virus particles prior to adsorption and interfering with post-entry processes of the viral replication cycle. This study highlights the antiviral potential of RE and its individual components, wFigurearranting further investigation into the mechanisms underlying their activity and their effects on other medically important flaviviruses.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication
Caroline Q. Sacramento, Gabrielle R. de Melo, … Thiago Souza·bioRxiv·Jul 6, 2016
- Old drugs with new tricks: Efficacy of fluoroquinolones to suppress replication of flaviviruses
S. L. P. Scroggs, C. C. Andrade, … S. L. Rossi·bioRxiv·Mar 30, 2020
- Discovery And Characterization of Small Molecule Inhibitors of Zika Virus Replication
- Phosphaphenalene Gold(I) Complexes as Broad-Spectrum Antivirals Against Emerging Flaviruses
Pablo Fuentes-Soriano, Blanca Palmero Casanova, … Rosario Sabariegos·bioRxiv·Feb 10, 2026
- Inhibitors of the Small Membrane (M) Protein Viroporin Prevent Zika Virus Infection
E. Brown, G. Swinscoe, … S. C. Griffin·eLifePeer-reviewed·Aug 23, 2024
- In vitro activity evaluation of Lippia alba essential oil against Zika virus
B. E. Quispe-Bravo, L. A. Sevilla Drozdek, … J. S. Sulca Herencia·bioRxiv·Jun 25, 2020